Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Argus Health
Covington
Boehringer Ingelheim
Citi
Deloitte
Johnson and Johnson
Farmers Insurance
Colorcon

Generated: April 19, 2018

DrugPatentWatch Database Preview

METHERGINE Drug Profile

« Back to Dashboard

When do Methergine patents expire, and when can generic versions of Methergine launch?

Methergine is a drug marketed by Edison Theraps Llc and is included in one NDA.

The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.
Drug patent expirations by year for METHERGINE
Pharmacology for METHERGINE
Ingredient-typeErgolines
Drug ClassErgot Derivative
Medical Subject Heading (MeSH) Categories for METHERGINE
Synonyms for METHERGINE
(2Z)-BUT-2-ENEDIOIC ACID; (4R,7R)-N-[(2S)-1-HYDROXYBUTAN-2-YL]-6-METHYL-6,11-DIAZATETRACYCLO[7.6.1.0(2),?.0(1)(2),(1)?]HEXADECA-1(15),2,9,12(16),13-PENTAENE-4-CARBOXAMIDE
(8|A)-9,10-Didehydro-N-[(1S)-1-(hydroxymethyl)propyl]-6-methyl-ergoline-8-carbox-amide Maleate
[8?(S)]-9,10-Didehydro-N-[1-(hydroxymethyl)propyl]-6-methylergoline-8-carboxamide maleate
432M618
57432-61-8
9,10-Didehydro-N-((S)-1-(hydroxymethyl)propyl)-6-methylergoline-8beta-carboxamide maleate (1:1) (salt)
9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8|A-carboxamide maleate salt
9,10-Didehydro-N-[(S)-1-(hydroxymethyl)propyl]-6-methylergoline-8beta-carboxamide maleate salt
AKOS024282479
AN-25473
B6347
C20H25N3O2
CCG-39168
CHEBI:6874
CHEMBL1200843
D00680
EINECS 260-734-4
Erezin
Erezingen
Ergoline-8-carboxamide, 9,10-didehydro-N-((1S)-1-(hydroxymethyl)propyl)-6-methyl-, (8beta)-, (2Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8-beta-(S))-,(Z)-2-butenedioate (1:1) (salt)
Ergoline-8-carboxamide, 9,10-didehydro-N-(1-(hydroxymethyl)propyl)-6-methyl-, (8beta(S))-, (Z)-2-butenedioate (1:1) (salt)
Ergonovine, methyl-, maleate (1:1)
EU-0100794
HMS1920N11
HMS2091F22
HMS2096K09
HMS3262O10
HMS501B19
IR84JPZ1RK
LP00794
LS-64364
M 2776
Maleic acid, methyl ergonovine
Methergine (TN)
Methergine maleate
Methergine maleate salt
Methyl Ergonovine Maleate Salt
Methylergobasine maleate
Methylergometrine for system suitability, European Pharmacopoeia (EP) Reference Standard
Methylergometrine maleate
Methylergometrine maleate (JP17)
Methylergometrine maleate, European Pharmacopoeia (EP) Reference Standard
Methylergonovine maleate
Methylergonovine maleate (USP)
Methylergonovine maleate [USAN]
Methylergonovine maleate salt
Methylergonovine maleate, United States Pharmacopeia (USP) Reference Standard
Methylergonovinemaleatesalt
METHYLERGONOVINIUM BIMALEATE
MFCD00078588
MolPort-003-666-807
N-[|A-(Hydroxymethyl)propyl]-D-lysergamide Maleate
NCGC00261479-01
NSC-757104
NSC757104
Pharmakon1600-01500404
PL009183
SCHEMBL239437
SPECTRUM1500404
ST056347
Tox21_500794
UNII-IR84JPZ1RK
USAF uctl-8

US Patents and Regulatory Information for METHERGINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Edison Theraps Llc METHERGINE methylergonovine maleate INJECTABLE;INJECTION 006035-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Edison Theraps Llc METHERGINE methylergonovine maleate TABLET;ORAL 006035-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Johnson and Johnson
Fish and Richardson
Cipla
Covington
Accenture
AstraZeneca
Moodys
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.